104 related articles for article (PubMed ID: 35121129)
21. Perilipin 3 Differentially Regulates Skeletal Muscle Lipid Oxidation in Active, Sedentary, and Type 2 Diabetic Males.
Covington JD; Noland RC; Hebert RC; Masinter BS; Smith SR; Rustan AC; Ravussin E; Bajpeyi S
J Clin Endocrinol Metab; 2015 Oct; 100(10):3683-92. PubMed ID: 26171795
[TBL] [Abstract][Full Text] [Related]
22. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.
Cheng JC; Bai A; Beckham TH; Marrison ST; Yount CL; Young K; Lu P; Bartlett AM; Wu BX; Keane BJ; Armeson KE; Marshall DT; Keane TE; Smith MT; Jones EE; Drake RR; Bielawska A; Norris JS; Liu X
J Clin Invest; 2013 Oct; 123(10):4344-58. PubMed ID: 24091326
[TBL] [Abstract][Full Text] [Related]
24. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
[TBL] [Abstract][Full Text] [Related]
25. Intensified autophagy compromises the efficacy of radiotherapy against prostate cancer.
Koukourakis MI; Kalamida D; Mitrakas A; Pouliliou S; Kalamida S; Sivridis E; Giatromanolaki A
Biochem Biophys Res Commun; 2015 May; 461(2):268-74. PubMed ID: 25887800
[TBL] [Abstract][Full Text] [Related]
26. Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models.
Huamani J; Willey C; Thotala D; Niermann KJ; Reyzer M; Leavitt L; Jones C; Fleishcher A; Caprioli R; Hallahan DE; Kim DW
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):237-46. PubMed ID: 18337021
[TBL] [Abstract][Full Text] [Related]
27. Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts.
Lip H; Amini MA; Zetrini A; Cai P; Abbasi AZ; Bristow RG; Rauth AM; Wu XY
Radiother Oncol; 2022 May; 170():213-223. PubMed ID: 35227733
[TBL] [Abstract][Full Text] [Related]
28. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W
BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682
[TBL] [Abstract][Full Text] [Related]
30. Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.
Liang W; Wang F; Chen Q; Dai J; Escara-Wilke J; Keller ET; Zimmermann J; Hong N; Lu Y; Zhang J
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1999-2012. PubMed ID: 31172267
[TBL] [Abstract][Full Text] [Related]
31. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
32. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
[TBL] [Abstract][Full Text] [Related]
33. Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
Qin C; Sheng Z; Huang X; Tang J; Liu Y; Xu T; Qiu X
Prostate; 2020 Sep; 80(13):1134-1144. PubMed ID: 32628304
[TBL] [Abstract][Full Text] [Related]
34. Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer.
Panda PK; Patra S; Naik PP; Praharaj PP; Mukhopadhyay S; Meher BR; Gupta PK; Verma RS; Maiti TK; Bhutia SK
J Cell Physiol; 2020 Mar; 235(3):2776-2791. PubMed ID: 31544977
[TBL] [Abstract][Full Text] [Related]
35. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
[TBL] [Abstract][Full Text] [Related]
36. Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.
Ghashghaei M; Niazi TM; Heravi M; Bekerat H; Trifiro M; Paliouras M; Muanza T
Prostate; 2018 Jan; 78(1):64-75. PubMed ID: 29134684
[TBL] [Abstract][Full Text] [Related]
37. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
Tian J; Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):230-6. PubMed ID: 20615620
[TBL] [Abstract][Full Text] [Related]
38. STAT3 as a target for sensitizing prostate cancer cells to irradiation.
Zhang Q; Zhou XM; Wei SZ; Cui DS; Deng KL; Liang G; Luo Y; Luo B; Liang XJ
J Radiat Res; 2022 Mar; 63(2):174-182. PubMed ID: 34970978
[TBL] [Abstract][Full Text] [Related]
39. Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.
Han S; Brenner JC; Sabolch A; Jackson W; Speers C; Wilder-Romans K; Knudsen KE; Lawrence TS; Chinnaiyan AM; Feng FY
Neoplasia; 2013 Oct; 15(10):1207-17. PubMed ID: 24204199
[TBL] [Abstract][Full Text] [Related]
40. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
